4DMedical

4DMedical FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of 4DMedical (4DX.AX) as of Oct 18, 2026 is 15.76 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 114.94 % — a change of -86.29% (lower).

FCF Conversion

15.76 %

YoY

-86.29%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of 4DMedical is 2026 15.76 % . FCF Conversion Rate (FCF/EBITDA) of 4DMedical was 2025 114.94 % . It decreases by -86.29% lower compared to the previous year.

The 4DMedical FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
108.81 AUD
Jan 1, 2020
40.08 AUD
Jan 1, 2021
71.17 AUD
Jan 1, 2022
115.27 AUD
Jan 1, 2023
74.33 AUD
Jan 1, 2024
86.63 AUD
Jan 1, 2025
114.94 AUD
Jan 1, 2026
15.76 AUD
The 4DMedical FCF Conversion history
YEARFCF ConversionYoY
15.76 %-86.29%
114.94 %+32.67%
86.63 %+16.55%
74.33 %-35.51%
115.27 %+61.96%
71.17 %+77.55%
40.08 %-63.16%
108.81 %-10.89%
122.11 %+47.61%
82.72 %-6.94%
88.89 %+86.19%
47.74 %0.00%
47.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

4DMedical Stock analysis

What does 4DMedical do? 4DMedical Ltd, headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in four-dimensional lung imaging technology. The company commercializes its patented XV Technology, enabling physicians to assess regional airflow and identify respiratory issues earlier through its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS. These solutions, delivered via a SaaS model, utilize existing hospital imaging equipment or the company's XV Scanner, with commercial rollout initiated through partnerships like I-MED Radiology Network, serving approximately 250 clinics nationwide. 4DMedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4DMedical stock

FCF Conversion Rate (FCF/EBITDA) of 4DMedical is 15.76 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of 4DMedical changed from 114.94 % to 15.76 %, representing a -86.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) 4DMedical since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s 4DMedical with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — 4DMedical

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — 4DMedical